The Role of Integrin α4β7 in HIV Pathogenesis and Treatment
Authors:
Open Access
- 24 February 2018
- journal article
- research article
- Published by Springer Nature in Current HIV/AIDS Reports
- Vol. 15 (2) , 127-135
Abstract
Purpose of Review Acute HIV infection is characterized by high-level viral replication throughout the body’s lymphoid system, particularly in gut-associated lymphoid tissues resulting in damage to structural components of gut tissue. This damage is irreversible and believed to contribute to the development of immune deficiencies. Antiretroviral therapy (ART) does not restore gut structure and function. Studies in macaques point to an alternative treatment strategy that may ameliorate gut damage. Integrin α4β7 mediates the homing of lymphocytes to gut tissues. Vedolizumab, a monoclonal antibody (mAb) antagonist of α4β7, has demonstrated efficacy and has been approved for the treatment of inflammatory bowel disease in humans. Here, we describe our current knowledge, and the gaps in our understanding, of the role of α4β7 in HIV pathogenesis and treatment. Recent Findings When administered to macaques prior to infection, a nonhuman primate analogue of vedolizumab prevents transmission of SIV. In combination with ART, this mAb facilitates durable virologic control following treatment interruption. Summary Targeting α4β7 represents a novel therapeutic approach to prevent and treat HIV infection.Keywords
This publication has 68 references indexed in Scilit:
- Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7PLOS Pathogens, 2012
- Structural specializations of α4β7, an integrin that mediates rolling adhesionJournal of Cell Biology, 2012
- The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7+/CD4+ T cells As Key Targets in Mucosal TransmissionPLOS Pathogens, 2011
- HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIVJournal of Translational Medicine, 2011
- The integrin α 4 β 7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1Proceedings of the National Academy of Sciences, 2009
- ORIGINAL ARTICLE: The Combination of the Gastrointestinal Integrin (α4β7) and Selectin Ligand Enhances T‐Cell Migration to the Reproductive Tract During Infection with Chlamydia trachomatisAmerican Journal of Reproductive Immunology, 2009
- Preliminary in vivo efficacy studies of a recombinant rhesus anti-α4β7 monoclonal antibodyCellular Immunology, 2009
- The mucosal barrier and immune activation in HIV pathogenesisCurrent Opinion in HIV and AIDS, 2008
- HIV infection and the gastrointestinal immune systemMucosal Immunology, 2007
- Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 InfectionPLOS Medicine, 2006